ARCHIVES

ASCO Calls For New Clinical Study Section, Endorses NCAB Action In Senate Testimony

This article is from The Cancer Letter archive.

Vol. 19 No. 30 | July 23, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area

November 8, 1985

NCCS Networker Volume 8 Issue 2, Summer 1994

June 13, 1994

Mayo Clinic Study Finds Samarium May Expand Options For Osteosarcoma

February 22, 2002

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002